Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,482 JPY | -1.33% | -1.66% | +5.93% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With a P/E ratio at 9.89 for the current year and 9.04 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.22 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.93% | 282M | - | ||
-12.86% | 8.57B | B | ||
+32.95% | 1.32B | - | ||
+6.76% | 419M | - | ||
+10.56% | 224M | - | - | |
-8.26% | 85.07M | - | - | |
-46.83% | 81.99M | C | ||
+20.94% | 59.57M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3341 Stock
- Ratings NIHON CHOUZAI Co.,Ltd.